MMP-2 Regulates Erk1/2 Phosphorylation and Aortic Dilatation in Marfan Syndrome

被引:99
作者
Xiong, Wanfen [1 ]
Meisinger, Trevor [1 ]
Knispel, Rebecca [1 ]
Worth, Jennifer M. [1 ]
Baxter, B. Timothy [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA
基金
美国国家卫生研究院;
关键词
aortic aneurysms; doxycycline; losartan; Marfan syndrome; matrix metalloproteinases; transforming growth factor-beta; BETA-BLOCKER THERAPY; TGF-BETA; MOUSE MODEL; TUMOR INVASION; IN-VITRO; ANEURYSM; PATHOGENESIS; TETRACYCLINE; DOXYCYCLINE; ACTIVATION;
D O I
10.1161/CIRCRESAHA.112.268268
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Aneurysm and dissection of the ascending thoracic aorta are the main cardiovascular complications of Marfan syndrome (MFS) resulting in premature death. Studies using mouse models of MFS have shown that activation of transforming growth factor-beta (TGF-beta) and the concomitant upregulation of matrix metalloproteinases (MMPs) contribute to aneurysm development. Our previous study showed that doxycycline delayed aneurysm rupture in a mouse model of MFS, Fbn1(mgR/mgR). Losartan has been shown to prevent aneurysms in another mouse model of MFS, Fbn1(C1039G/+), through inhibition of the Erk1/2 pathway. However, the role of MMP-2 in MFS and effect of losartan on the lifespan of MFS mice remain unknown. Objective: We investigated the role of MMP-2 in MFS and compared the effects of losartan and doxycycline on aortic dilatation and survival in Fbn1(mgR/mgR) mice. Methods and Results: By life table analysis, we found that losartan and doxycycline improved the survival of Fbn1(mgR/mgR) mice. Gelatin zymography and Western blot data showed that only doxycycline inhibited MMP-2 expression, whereas both drugs decreased Erk1/2 phosphorylation. When combined, only one of nine mice died within the 30-week study; aortic histology and diameter were normalized and the effects on Smad2 phosphorylation was additive. To further explore the role of MMP-2 in MFS, we created MMP-2-deficient Fbn1(mgR/mgR) mice. MMP-2 deletion inhibited activation of TGF-beta and phosphorylation of Erk1/2 and Smad2 and prolonged the lifespan of the mice. Conclusions: These studies demonstrated that inhibition of MMP-2 by doxycycline delayed the manifestations of MFS, in part, through its ability to decrease active TGF-beta and the noncanonical signaling cascade downstream of TGF-beta. This study further suggested that targeting TGF-beta signaling at different points might be a more effective strategy for inhibiting disease progression. (Circ Res. 2012; 110:e92-e101.)
引用
收藏
页码:E92 / E101
页数:10
相关论文
共 49 条
[1]   Phenotypic heterogeneity of marfan-like connective tissue disorders associated with mutations in the transforming growth factor-β receptor genes [J].
Akutsu, Koichi ;
Morisaki, Hiroko ;
Takeshita, Satoshi ;
Sakamoto, Shingo ;
Tamori, Yuiichi ;
Yoshimuta, Tsuyoshi ;
Yokoyama, Naoyuki ;
Nonogi, Hiroshi ;
Ogino, Hitoshi ;
Morisaki, Takayuki .
CIRCULATION JOURNAL, 2007, 71 (08) :1305-1309
[2]   Molecular genetics of Marfan syndrome [J].
Boileau, C ;
Jondeau, G ;
Mizuguchi, T ;
Matsumoto, N .
CURRENT OPINION IN CARDIOLOGY, 2005, 20 (03) :194-200
[3]   A fibrillin-1-fragment containing the elastin-binding-protein GxxPG consensus sequence upregulates matrix metalloproteinase-1: biochemical and computational analysis [J].
Booms, P ;
Ney, A ;
Barthel, F ;
Moroy, G ;
Counsell, D ;
Gille, C ;
Guo, G ;
Pregla, R ;
Mundlos, S ;
Alix, AJP ;
Robinson, PN .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2006, 40 (02) :234-246
[4]   RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: A potential factor in the pathogenesis of the Marfan syndrome [J].
Booms, P ;
Pregla, R ;
Ney, A ;
Barthel, F ;
Reinhardt, DP ;
Pletschacher, A ;
Mundlos, S ;
Robinson, PN .
HUMAN GENETICS, 2005, 116 (1-2) :51-61
[5]   Losartan decreases plasma levels of TGF-β1 in transplant patients with chronic allograft nephropathy [J].
Campistol, JM ;
Iñigo, P ;
Jimenez, W ;
Lario, S ;
Clesca, PH ;
Oppenheimer, F ;
Rivera, F .
KIDNEY INTERNATIONAL, 1999, 56 (02) :714-719
[6]  
Carmeli E, 2009, J MUSCULOSKEL NEURON, V9, P81
[7]   Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and-9 [J].
Chung, Ada W. Y. ;
Yang, H. H. Clarice ;
Radomski, Marek W. ;
van Breemen, Cornelis .
CIRCULATION RESEARCH, 2008, 102 (08) :E73-E85
[8]   Recent progress towards a molecular understanding of Marfan syndrome [J].
Dietz, HC ;
Loeys, B ;
Carta, L ;
Ramirez, F .
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2005, 139C (01) :4-9
[9]   MUTATIONS IN THE HUMAN GENE FOR FIBRILLIN-1 (FBN1) IN THE MARFAN-SYNDROME AND RELATED DISORDERS [J].
DIETZ, HC ;
PYERITZ, RE .
HUMAN MOLECULAR GENETICS, 1995, 4 :1799-1809
[10]   MARFAN-SYNDROME CAUSED BY A RECURRENT DENOVO MISSENSE MUTATION IN THE FIBRILLIN GENE [J].
DIETZ, HC ;
CUTTING, GR ;
PYERITZ, RE ;
MASLEN, CL ;
SAKAI, LY ;
CORSON, GM ;
PUFFENBERGER, EG ;
HAMOSH, A ;
NANTHAKUMAR, EJ ;
CURRISTIN, SM ;
STETTEN, G ;
MEYERS, DA ;
FRANCOMANO, CA .
NATURE, 1991, 352 (6333) :337-339